Drug intelligence / Profile preview

PermeaDerm

Development stage
Unknown
Lead developer
Stedical Scientific
Administration
Topical
01

Overview

PermeaDerm is a biosynthetic wound dressing designed to function as a temporary skin substitute for the treatment of partial-thickness burns, donor sites, and chronic wounds. Developed by Dr. Aubrey Woodroof, the product consists of a transparent silicone membrane bonded to a nylon mesh that is coated with porcine-derived Type I collagen. Its unique design features variable porosity (slits) that allow for the controlled passage of wound exudate while maintaining a moist healing environment. PermeaDerm adheres to the wound bed through fibrin-collagen bonding, providing a physical barrier against infection and reducing pain by protecting exposed nerve endings. It is available in different configurations tailored for specific clinical applications, such as PermeaDerm B for burns and PermeaDerm C for chronic ulcers, and is designed to remain in place until the wound heals or is ready for autografting.

Brand names
PermeaDermPermeaDerm BPermeaDerm CPermeaDerm D
Other names
PermeaDerm Biosynthetic Wound Dressing
02

Targets

COL1 (Collagen type I)Fibrin (Factor Ia)

Beyond the preview

Go deeper on PermeaDerm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PermeaDerm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call